Neogen: Q4 Earnings Insights

 

Shares of Neogen NEOG decreased 0.8% in pre-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share decreased 51.61% over the past year to $0.15, which missed the estimate of $0.16.

Revenue of $127,425,000 higher by 16.82% from the same period last year, which beat the estimate of $122,320,000.

Looking Ahead

Neogen hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

How To Listen To The Conference Call

Date: Jul 20, 2021

Time: 11:00 AM

ET Webcast URL: https://www.webcaster4.com/Webcast/Page/1224/41872

Recent Stock Performance

52-week high: $97.70

52-week low: $43.42

Price action over last quarter: Up 3.05%

Company Description

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (57% of sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for global food and feed processing companies. In animal safety (43% of sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Neogen is also a market leader in testing for therapeutic drugs for farm and racing animals. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the other 40% of sales.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!